Tijana Markovic
Ljubljana, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Unravelling immunomodulatory effects of bisphenol A substitutes on human macrophages, T and B lymphocytes using in vitro models.
Journal: Ecotoxicology and environmental safety
Published: February 01, 2025
The immunopathogenesis of a cytokine storm: The key mechanisms underlying severe COVID-19.
Journal: Cytokine & growth factor reviews
Published: October 22, 2024
The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies.
Journal: International journal of molecular sciences
Published: December 27, 2021
EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells.
Journal: Biochemical pharmacology
Published: September 28, 2020
Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
Journal: Toxicology letters
Published: October 20, 2017
Structural features of subtype-selective EP receptor modulators.
Journal: Drug discovery today
Published: May 12, 2016
Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol.
Journal: Chemico-biological interactions
Published: April 01, 2015
Characterization of human lymphoblastoid cell lines as a novel in vitro test system to predict the immunotoxicity of xenobiotics.
Journal: Toxicology letters
Published: October 10, 2014
Chemo-sensitizing effects of EP4 receptor-induced inactivation of nuclear factor-κB.
Journal: European journal of pharmacology
Published: February 06, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026